Takashi Fukuoka - Concepedia

Author

Takashi Fukuoka

Also Known As

Hiroki Endo, Mikie Kubota, TAKASHI FUKUOKA, Takashi FUKUOKA, Takashi Fukuoka, Takeshi Fukuda, Toshiro Iizuka, Yoko Kamai

Publications

800

Citations

H-Index

Concepts

All Affiliations

Daiichi-Sankyo (Japan)Biomedical Research Laboratories (United States)Daiichi Sankyo (Germany)Toho University UCLA Medical Center

About

Takashi Fukuoka is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	539
2	Health Sciences	6	6	165
3	Natural Sciences	3	3	103
4	Biochemistry	2	2	61
5	Biomolecular Engineering	2	2	102

Takashi Fukuoka

Publications

698

Citations

H-Index

Page 1

	Year	Citations
New Model of Oropharyngeal Candidiasis in Mice Yasuki Kamai, Mikie Kubota, Yoko Kamai, Antimicrobial Agents and Chemotherapy Cotton Wool BallsOropharyngeal CandidiasisAntifungal AgentNew ModelOral Cavity	2001	112
Genetic Basis for Differential Activities of Fluconazole and Voriconazole against <i>Candida krusei</i> Takashi Fukuoka, Douglas A. Johnston, Carol A. Winslow, Antimicrobial Agents and Chemotherapy Cytochrome P450 SterolAntifungal AgentFungal PathogenAntifungal AgentsMedicine	2003	95
Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellularein vitro and in vivo Tetsufumi Koga, Takashi Fukuoka, Norio Doi, Journal of Antimicrobial Chemotherapy	2004	86
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin Hitoshi Hotoda, Miyuki Furukawa, Makiko Daigo, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryAzepan-2-one MoietyMedicineAntibacterial Agent	2003	60
In Vitro and In Vivo Antibacterial Activities of CS-023 (RO4908463), a Novel Parenteral Carbapenem Tetsufumi Koga, Tomomi Abe, Harumi Inoue, Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesAntibioticsLung Infection ModelVivo Antibacterial Activities	2005	53
Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds Hitoshi Hotoda, Makiko Daigo, Miyuki Furukawa, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBioorganic ChemistryDerivativesNatural Sciences	2003	42
Antifungal Activities of R-135853, a Sordarin Derivative, in Experimental Candidiasis in Mice Yasuki Kamai, Masayo Kakuta, Takahiro Shibayama, Antimicrobial Agents and Chemotherapy Experimental CandidiasisFluconazole-refractory InfectionsMedicinal FungiAntimicrobial ChemotherapyFluconazole-resistant Strains	2004	35
Potent In Vitro Activity of Tomopenem (CS-023) against Methicillin-Resistant <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> Tetsufumi Koga, Nobuhisa Masuda, Masayo Kakuta, Antimicrobial Agents and Chemotherapy Antibacterial ActivityAntimicrobial ChemotherapyDrug ResistanceInfection ControlAntimicrobial Resistance	2008	33
Synthesis and Structure-activity Relationships of Novel Parenteral Carbapenems, CS-023 (R-115685) and Related Compounds Containing an Amidine Moiety Isao Kawamoto, Yasuo Shimoji, Osamu Kanno, The Journal of Antibiotics	2003	31
[43] In vitro and in Vivo models of bacterial biofilms Hiroshi Yasuda, Tetsufumi Koga, Takashi Fukuoka Methods in enzymology on CD-ROM/Methods in enzymology BiofilmsPathogenic MicrobiologyAntimicrobial SusceptibilityQuantitative MicrobiologyMicrobiology	1999	30

Page 1